SMTL ID : 3o51.1

Crystal structure of anthranilamide 10 bound to AuroraA

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.20 Å

Oligo State

monomer

Ligands

1 x LJF: N-[4-({3-[5-fluoro-2-(methylideneamino)pyrimidin-4-yl]pyridin-2-yl}oxy)phenyl]-2-(phenylamino)benzamide(Non-covalent)

LJF.1: 20 residues within 4Å: Chain A: L.15, G.16, K.17, F.20, V.23, A.36, L.40, L.54, E.57, V.58, Q.61, L.72, L.84, L.86, E.87, Y.88, A.89, L.139, A.149, F.151 15 PLIP interactions: 15 interactions with chain A Hydrophobic interactions: A:F.20, A:V.23, A:V.23, A:L.40, A:L.54, A:L.54, A:V.58, A:Q.61, A:L.72, A:L.84, A:L.86, A:A.149, A:F.151, A:F.151 Hydrogen bonds: A:A.89

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Cee, V.J. et al., Discovery of a potent, selective, and orally bioavailable pyridinyl-pyrimidine phthalazine aurora kinase inhibitor. J.Med.Chem. (2010)

Release Date

2010-08-18

Peptides

cDNA FLJ58295, highly similar to Serine/threonine-protein kinase 6: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

cDNA FLJ58295, highly similar to Serine/threonine-protein kinase 6

Related Entries With Identical Sequence